Is Biogen Inc. (BIIB) a Buy, Sell, or Hold?
Biogen Inc.
NASDAQ:BIIB
$191.95 USD
-$17.08 (-8.17%)
- Volume
- 3.9M
- Average Volume
- 1.2M
- Market Capitalization
- $28.34B
- P/E Ratio
- 20.49
- Dividend Yield
- 0.00%
- Price Target
- $225.00
- Year High
- $219.72
- Year Low
- $121.05
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.06
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
54
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
71
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 133.56K
BIIB Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
BIIB Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| HAWKINS WILLIAM A | director | 2026-06-09 | A-Award | 0 | 2026-06-11 |
| SHERWIN STEPHEN A | director | 2026-06-09 | A-Award | 0 | 2026-06-11 |
| Rowinsky Eric K | director | 2026-06-09 | A-Award | 0 | 2026-06-11 |
| Mantas Jesus B | director | 2026-06-09 | A-Award | 0 | 2026-06-11 |
| LANGER SUSAN | director | 2026-06-09 | A-Award | 0 | 2026-06-11 |
| Patolawala Monish D | director | 2026-06-09 | A-Award | 0 | 2026-06-11 |
| Pangalos Menelas N | director | 2026-06-09 | A-Award | 0 | 2026-06-11 |
| Pangalos Menelas N | director | 2026-06-09 | M-Exempt | 0 | 2026-06-11 |
| Pangalos Menelas N | director | 2026-06-09 | M-Exempt | 0 | 2026-06-11 |
| Minor Lloyd | director | 2026-06-09 | A-Award | 0 | 2026-06-11 |
| Freire Maria C | director | 2026-06-09 | A-Award | 0 | 2026-06-11 |
| Keeney Adam | officer: Head of Corporate Development | 2026-05-01 | M-Exempt | 0 | 2026-05-05 |
| Keeney Adam | officer: Head of Corporate Development | 2026-05-01 | F-InKind | 187.06 | 2026-05-05 |
| Keeney Adam | officer: Head of Corporate Development | 2026-05-01 | M-Exempt | 0 | 2026-05-05 |
| Godbout Sean | officer: Chief Accounting Officer | 2026-04-01 | M-Exempt | 0 | 2026-04-03 |
| Godbout Sean | officer: Chief Accounting Officer | 2026-04-01 | F-InKind | 183.78 | 2026-04-03 |
| Godbout Sean | officer: Chief Accounting Officer | 2026-04-01 | M-Exempt | 0 | 2026-04-03 |
| Viehbacher Christopher | director, officer: President and CEO | 2026-02-13 | A-Award | 0 | 2026-02-17 |
| Singhal Priya | officer: Head of Development | 2026-02-13 | A-Award | 0 | 2026-02-17 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | 2026-02-12 | P-Purchase | 195.035 | 2026-02-17 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | 2026-02-13 | A-Award | 0 | 2026-02-17 |
| Kramer Robin | officer: Chief Financial Officer | 2026-02-13 | A-Award | 0 | 2026-02-17 |
| Keeney Adam | officer: Head of Corporate Development | 2026-02-13 | A-Award | 0 | 2026-02-17 |
| Izzar Rachid | officer: Head of Global Product Strat. | 2026-02-13 | A-Award | 0 | 2026-02-17 |
| Grogan Jane | officer: Head of Research | 2026-02-13 | A-Award | 0 | 2026-02-17 |
| Gregory Ginger | officer: EVP, Human Resources | 2026-02-13 | A-Award | 0 | 2026-02-17 |
| Godbout Sean | officer: Chief Accounting Officer | 2026-02-13 | A-Award | 0 | 2026-02-17 |
| ALEXANDER SUSAN H | officer: EVP Chief Legal Officer | 2026-02-13 | A-Award | 0 | 2026-02-17 |
| Viehbacher Christopher | director, officer: President and CEO | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Viehbacher Christopher | director, officer: President and CEO | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Viehbacher Christopher | director, officer: President and CEO | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Viehbacher Christopher | director, officer: President and CEO | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Viehbacher Christopher | director, officer: President and CEO | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Viehbacher Christopher | director, officer: President and CEO | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Singhal Priya | officer: Head of Development | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Singhal Priya | officer: Head of Development | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Singhal Priya | officer: Head of Development | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Singhal Priya | officer: Head of Development | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Singhal Priya | officer: Head of Development | 2026-02-09 | S-Sale | 199.83 | 2026-02-10 |
| Singhal Priya | officer: Head of Development | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Singhal Priya | officer: Head of Development | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Kramer Robin | officer: Chief Financial Officer | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Kramer Robin | officer: Chief Financial Officer | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Kramer Robin | officer: Chief Financial Officer | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Kramer Robin | officer: Chief Financial Officer | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Kramer Robin | officer: Chief Financial Officer | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Kramer Robin | officer: Chief Financial Officer | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Kramer Robin | officer: Chief Financial Officer | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Kramer Robin | officer: Chief Financial Officer | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Kramer Robin | officer: Chief Financial Officer | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Keeney Adam | officer: Head of Corporate Development | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Keeney Adam | officer: Head of Corporate Development | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Keeney Adam | officer: Head of Corporate Development | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Keeney Adam | officer: Head of Corporate Development | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Keeney Adam | officer: Head of Corporate Development | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Keeney Adam | officer: Head of Corporate Development | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Izzar Rachid | officer: Head of Global Product Strat. | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Izzar Rachid | officer: Head of Global Product Strat. | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Izzar Rachid | officer: Head of Global Product Strat. | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Izzar Rachid | officer: Head of Global Product Strat. | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Izzar Rachid | officer: Head of Global Product Strat. | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Izzar Rachid | officer: Head of Global Product Strat. | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Izzar Rachid | officer: Head of Global Product Strat. | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Izzar Rachid | officer: Head of Global Product Strat. | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Izzar Rachid | officer: Head of Global Product Strat. | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Grogan Jane | officer: Head of Research | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Grogan Jane | officer: Head of Research | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Grogan Jane | officer: Head of Research | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Grogan Jane | officer: Head of Research | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Grogan Jane | officer: Head of Research | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Grogan Jane | officer: Head of Research | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Gregory Ginger | officer: EVP, Human Resources | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Gregory Ginger | officer: EVP, Human Resources | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Gregory Ginger | officer: EVP, Human Resources | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Gregory Ginger | officer: EVP, Human Resources | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Gregory Ginger | officer: EVP, Human Resources | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Gregory Ginger | officer: EVP, Human Resources | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Gregory Ginger | officer: EVP, Human Resources | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Gregory Ginger | officer: EVP, Human Resources | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Gregory Ginger | officer: EVP, Human Resources | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Godbout Sean | officer: Chief Accounting Officer | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Godbout Sean | officer: Chief Accounting Officer | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Godbout Sean | officer: Chief Accounting Officer | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Godbout Sean | officer: Chief Accounting Officer | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Godbout Sean | officer: Chief Accounting Officer | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Godbout Sean | officer: Chief Accounting Officer | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Godbout Sean | officer: Chief Accounting Officer | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |
| Godbout Sean | officer: Chief Accounting Officer | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| Godbout Sean | officer: Chief Accounting Officer | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| ALEXANDER SUSAN H | officer: EVP Chief Legal Officer | 2026-02-06 | M-Exempt | 0 | 2026-02-10 |
| ALEXANDER SUSAN H | officer: EVP Chief Legal Officer | 2026-02-06 | F-InKind | 201.18 | 2026-02-10 |